Hangzhou Bio-Sincerity Pharma-Tech Co's quarterly market cap
declined
from Mar. 2024 (¥8,115 Mil) to Jun. 2024 (¥6,326 Mil) and
declined
from Jun. 2024 (¥6,326 Mil) to Sep. 2024 (¥5,228 Mil).
Hangzhou Bio-Sincerity Pharma-Tech Co's annual market cap
declined
from Dec. 2021 (¥9,293 Mil) to Dec. 2022 (¥7,389 Mil) and
declined
from Dec. 2022 (¥7,389 Mil) to Dec. 2023 (¥7,091 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Hangzhou Bio-Sincerity Pharma-Tech Co's Enterprise Value for Today is ¥4,155 Mil.
Hangzhou Bio-Sincerity Pharma-Tech Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Hangzhou Bio-Sincerity Pharma-Tech Co Market Cap Chart
Competitive Comparison of Hangzhou Bio-Sincerity Pharma-Tech Co's Market Cap
For the Drug Manufacturers - General subindustry, Hangzhou Bio-Sincerity Pharma-Tech Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hangzhou Bio-Sincerity Pharma-Tech Co's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hangzhou Bio-Sincerity Pharma-Tech Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Hangzhou Bio-Sincerity Pharma-Tech Co's Market Cap falls into.
Hangzhou Bio-Sincerity Pharma-Tech Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Hangzhou Bio-Sincerity Pharma-Tech Co Market Cap Related Terms
Thank you for viewing the detailed overview of Hangzhou Bio-Sincerity Pharma-Tech Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Hangzhou Bio-Sincerity Pharma-Tech Co Business Description
Hangzhou Bio-Sincerity Pharma-Tech Co Ltd is a pharmaceutical technology research and development company. The company's business covers drug discovery, pharmaceutical research, clinical research, and registration application.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:301096 has been successfully added to your 